Article · 2 Jun 2026
Conference abstract
Novel anti-cancer binary system activated by bacteriophage HK022 integrase
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gene therapy is a promising tool for cancer therapeutics. However, a major obstacle that persists is the lack of specificity of the expressed toxic gene against cancer cells. Binary systems based on site-specific recombination are one of the most effective potential approaches for cancer gene therapy. In these systems, a cancer specific promoter expresses a site-specific recombinase/integrase that in turn controls the expression of a toxin gene. We have developed a new HK022 bacteriophage integrase (Int) based binary system that activates a diphtheria toxin (DTA) gene expression specifically in cancer cells (Fig 1. A). The efficiency, and specificity of the system were assessed in-vitro and in-vivo in a lung cancer mouse model. The system presents a significant efficiency and specificity in series of criteria. Strikingly, employment of the developed system to treat mice with lung cancer demonstrates significantly increased longevity (Fig.1 B). The molecular factors that contribute to the system specificity will be described. Recent Publications: 1. Elias A et al. (2016) Cancer-specific binary expression system activated in mice by bacteriophage HK022 Integrase. Sci. Rep. 6:24971. 2. Yucheng Xu and Amir Goldkorn (2016) Telomere and telomerase therapeutics in cancer. Genes 7:22. 3. Chen X, Scapa J E, Liu D X and Godbey W T (2016) Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5. J Gene Med. 18:89. 4. Dalit Landesman-Milo, Srinivas Ramishetti and Dan Peer (2015) Nanomedicine as an emerging platformformetastatic lung cancer therapy. Cancer Metastasis Rev. 34:291. 5. Hao Yin, Rosemary L Kanasty, Ahmed A Eltoukhy, Arturo J Vegas, J Robert Dorkin, Anderson. (2014) Non-viral vectors for gene-based therapy Nature Reviews Genetics 15:541.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Amer Elias”
